New York, New York, May 14, 2008 /PRNewswire/ -- HEALTHPOINTCAPITAL, LLC announced today that it has appointed Dr. Hansen A. Yuan to its Scientific Advisory Board. Dr. Yuan is a preeminent clinician and researcher and has been honored worldwide for his leadership and innovation in spine.
Dr. Yuan currently serves as Professor Emeritus, Department of Orthopaedic and Neurological Surgery at the SUNY Health Science Center and has been a Presidential Guest and frequent lecturer at a number of hospitals and society meetings in China. Dr. Yuan is also a charter member and current president of the Spine Arthroplasty Society and is a member of numerous professional societies including the North American Spine Society and the Orthopaedic Research Society.
“Dr. Yuan’s distinguished career in spine surgery and the science of the spine makes his addition to our Scientific Advisory Board invaluable,” said John Foster, Chairman and Managing Director at HEALTHPOINTCAPITAL. Mr. Foster added, “We believe Dr. Yuan will complement our Scientific Advisory Board with his global perspective and unparalleled knowledge of spine technology and worldwide intellectual property rights.”
“I look forward to working with HEALTHPOINTCAPITAL and its Scientific Advisory Board,” stated Dr. Yuan. “This research-based team represents the largest pool of capital dedicated to the musculoskeletal space, which enables the firm to develop novel technologies at their portfolio companies and make a positive difference in patients’ lives.”
For More Information:
John McCormick
HealthpointCapital, LLC
212.935.7780
www.healthpointcapital.com
About HEALTHPOINTCAPITAL
HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on the orthopedic and dental device businesses. HealthpointCapital has $650 million of institutional capital under management and is the only firm of its kind to focus exclusively on the $37 billion worldwide orthopedic and dental device industry.
The HealthpointCapital team brings a cumulative 100 years of experience in healthcare technology, research and investing to help their clients capitalize on the explosive growth and unique investment opportunities in the musculoskeletal industry.
